GLP-1s May Change What You Want to Eat

You know that moment when a food you used to really want suddenly just… doesn't sound that interesting?

The fries arrive. They're hot. They're crispy. They're objectively doing everything a fry is supposed to do.

And somehow you're like, I'm good.

Who is she?

If you've noticed something like this while taking a GLP-1, you may not be imagining it.

Research suggests GLP-1 medications may affect food cravings and responses to food cues, not just how full you feel. In a 2025 randomized trial, people receiving tirzepatide reported lower appetite and fewer cravings and showed reduced responses to certain food cues.

A 2025 randomized study published in Nature Medicine looked at what happened to appetite and eating behaviour in adults with overweight or obesity taking tirzepatide. The researchers weren't just interested in how much people ate. They looked at hunger, cravings, reactions to food around them and even what happened in the brain when participants were shown pictures of food.

Feeling full is only part of the story

After three weeks, participants taking tirzepatide reported lower overall appetite and fewer food cravings than those receiving placebo.

And we're talking about actual cravings here. Cravings for high-fat foods, sweets, carbohydrates and starches, and things like pizza, burgers and fries all decreased. Fruit and vegetable cravings, interestingly, didn't show the same difference.

Participants also became less responsive to food simply being there.

You know the phenomenon. You're not particularly hungry, but someone puts warm bread on the table and suddenly apparently we're having bread.

Researchers measured that kind of response too. Tirzepatide reduced the tendency to overeat in response to external cues, such as seeing or smelling food, as well as internal cues including stress and anxiety.

That's a little different from simply getting full faster.

Your brain may be involved too

This is where the study gets particularly interesting.

Researchers put participants through brain imaging while showing them pictures of different foods. At week three, tirzepatide was associated with reduced activation in several brain regions involved in appetite and food reward when participants looked at high-fat, high-sugar foods.

That doesn't mean researchers have found the biological on/off switch for "food noise." They haven't.

But it does give us an intriguing glimpse into why some people describe food as feeling less… loud.

The dessert can still be sitting there. Your brain may simply be less interested in entering negotiations with it.

Do GLP-1s actually change your food preferences?

This study does not show that GLP-1s completely rewrite your food preferences.

Participants ate less overall, but researchers didn't find evidence that tirzepatide selectively changed the proportion of carbohydrates, fat or protein they consumed.

And this was a small, short study: 114 adults were randomized and the treatment period lasted six weeks. It gives us an interesting look at what can happen early in treatment, not a guarantee of what every person will experience or what happens over years.

There's also a detail worth knowing when reading the research: several study authors were affiliated with Eli Lilly, the manufacturer of tirzepatide. That doesn't invalidate a randomized trial, but funding and author affiliations are useful context when interpreting research.

What this can mean in real life

Having food occupy less mental real estate can feel incredibly freeing.

But there's a flip side.

When hunger and cravings get quieter, the reminders to actually eat can get quieter too.

Suddenly it's 3 p.m., you've had half a coffee and four almonds, and you're wondering why your battery feels like it's at 7%.

That's where eating can become a little more intentional.

Have I actually eaten today? Did I get some protein? Have I had enough fluids? Did anything green enter the building?

Not every meal needs to be nutritionally perfect. And nobody needs another full-time job disguised as a wellness routine.

But when the signals around food change, the way you respond to them may need to change too.

And maybe that's one of the more fascinating things we're learning about these medications:

Food doesn't necessarily disappear from your life. It may simply take up a little less space in your head.

Sources & Further Reading

Nature Medicine (2025)
“Tirzepatide on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial”

A randomized six-week phase 1 trial involving 114 adults without diabetes with BMI between 27 and 50, examining energy intake, appetite, cravings, eating behaviour and neural responses to food cues.

PubMed
Secondary analysis examining food cravings and preferences during tirzepatide treatment.